News | Congenital Heart | January 30, 2019

Climate Change May Increase Congenital Heart Defects

Study reinforces need for pregnant women to be aware of the dangers of extreme heat exposure

Climate Change May Increase Congenital Heart Defects

January 30, 2019 — Rising temperatures stemming from global climate change may increase the number of infants born with congenital heart defects (CHD) in the U.S. over the next two decades, according to new research in the Journal of the American Heart Association.1 This may also result in as many as 7,000 additional cases over an 11 year-period in eight representative states — Arkansas, Texas, California, Iowa, North Carolina, Georgia, New York and Utah.

“Our findings underscore the alarming impact of climate change on human health and highlight the need for improved preparedness to deal with the anticipated rise in a complex condition that often requires lifelong care and follow-up,” said study senior author Shao Lin, M.D., Ph.D., MPH, professor in the School of Public Health at University of Albany (N.Y.). “It is important for clinicians to counsel pregnant women and those planning to become pregnant on the importance of avoiding extreme heat, particularly 3-8 weeks post conception, the critical period of pregnancy.”

Congenital heart defects are the most common birth defect in the United States affecting some 40,000 newborns each year, according to the Centers for Disease Control and Prevention.

“Our results highlight the dramatic ways in which climate change can affect human health and suggest that pediatric heart disease stemming from structural heart malformations may become an important consequence of rising temperatures,” said the leading author Wangjian Zhang, M.D., Ph.D., a post-doctoral research fellow at the University of Albany.

The projected increase in children with congenital heart disease will pose greater demand on the medical community caring for newborns with heart disease in their infancy and well beyond.

While previous research has found a link between maternal heat exposure and the risk for heart defects in the offspring, the precise mechanisms remain unclear. Studies in animals suggest that heat may cause fetal cell death or interfere with several heat-sensitive proteins that play a critical role in fetal development, the researchers say.

The estimates in the current study are based on projections of the number of births between 2025 and 2035 in the United States, and the anticipated rise in average maternal heat exposure across different regions as a result of global climate change. The greatest percentage increases in the number of newborns with CHD will occur in the Midwest, followed by the Northeast and South.

In their analysis, the researchers used climate change forecasts obtained from NASA and the Goddard Institute for Space Studies. They improved the spatial and temporal resolutions of the forecasts, simulated changes in daily maximum temperatures by geographic region, and then calculated the anticipated maternal heat exposure per region for spring and summer. For each pregnancy and region, they defined three exposure indicators:

1) The count of excessively hot days (EHD) as the number of days exceeding the 90th  (EHD90) or 95th (EHD95) percentile for the same season of the baseline period at the same region;

2) The frequency of extreme heat events (EHE) as the number of occurrences of at least three consecutive EHD 90 days or two consecutive EHD 95 days; and

3) The duration of EHE as the number of days for the longest EHE within the 42-day period.

To obtain a parameter for congenital heart defect (CHD) burden projections, the investigators used data from an earlier study, also led by Lin, which gauged the risk of congenital heart defects based on maternal heat exposure for births occurring between 1997 and 2007.2 The researchers then integrated the heat-CHD associations identified during the baseline period with the projected increases in maternal heat exposure over a period between 2025 and 2035 to estimate the potential changes in CHD burden.

“Although this study is preliminary, it would be prudent for women in the early weeks of pregnancy to avoid heat extremes similar to the advice given to persons with cardiovascular and pulmonary disease during heart spells,” said Shao Lin, M.D., Ph.D., M.P.H., associate director of environmental health services, University at Albany, State University of New York.

For more information: www.ahajournals.org/journal/jaha

References

1. Zhang W., Spero T.L., Nolte C.G., et al. Projected Changes in Maternal Heat Exposure During Early Pregnancy and the Associated Congenital Heart Defect Burden in the United States. Journal of the American Heart Association, Jan. 30, 2019. https://doi.org/10.1161/JAHA.118.010995

2. Lin S., Lin Z., Ou Y., et al. Maternal ambient heat exposure during early pregnancy in summer and spring and congenital heart defects – A large US population-based, case-control study. Environment International, June 8, 2018. https://doi.org/10.1016/j.envint.2018.04.043


Related Content

News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

Home April 08, 2024
Home
Subscribe Now